Web31 Mar 2024 HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer Read more 14 Mar 2024 HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China Read more 13 Mar 2024 HUTCHMED Confirms No Assets Held at Silicon Valley Bank … Web19 dec. 2024 · HUTCHMED Initiates Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Colorectal Cancer HUTCHMED (China) Limited …
Takeda To Acquire Exclusive Worldwide (ex-China) License of …
Web2 mei 2024 · The FDA's communication - known as a Complete Response Letter - to Hutchmed said its treatment for neuroendocrine tumors requires data from a study more … Web2 mei 2024 · Hutchmed Ltd said on Monday the US Food and Drug Administration has declined to approve its cancer drug, citing the need for a multi-regional clinical trial, … cottonwood rexburg idaho
HUTCHMED (China) Limited hebt Präsentationen auf der …
Web31 mrt. 2024 · Hutchmed dient nieuwe geneesmiddelenaanvraag in bij US FDA voor behandeling van kanker. (Alliance News) - Hutchmed (China) Ltd zei vrijdag dat het de … Web18 jun. 2024 · Hutchmed — recently renamed from Chi-Med, or Hutchison China MediTech — will look to raise $603 million as part of a Hong Kong IPO that serves as a … Web12 apr. 2024 · HUTCHMED Limited heeft aangekondigd dat nieuwe en bijgewerkte klinische en niet-klinische gegevens met betrekking tot vijf HUTCHMED-onderzoekskandidaten voor geneesmiddelen zullen worden ... breckinridge county fair kentucky